Document is current
Any future updates will be listed below
-
Authors
Song, Yeo-Jin
Kim, Hyoungyoung
Cho, Soo-Kyung
Kim, Hye Won
Lim, Chaewhi
Nam, Eunwoo
Choi, Chan-Bum
Kim, Tae-Hwan
Jun, Jae-Bum
Bae, Sang-Cheol
Yoo, Dae Hyun
Hong, Su Jin
Yoo, Seung-Jin
Lee, Youkyung
Sung, Yoon-Kyoung
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
JW Pharmaceuticals
Ministry of Health & Welfare, Republic of Korea (HV23C1762)
- License Information
-
More Information
Article History
Received: 30 January 2024
Accepted: 1 July 2024
First Online: 19 July 2024
Declarations
:
: This study complied with the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Hanyang University Hospital (IRB no. HYUH 2016-06-019). Written informed consent was obtained from all patients at the time of enrolment.
: Not applicable.
: DHY has received research grants from Celltrion, served as a consultant for Celltrion and is a member of the Speakers’ Bureau of Celltrion and Celltrion Healthcare. YKS has received research grants from Bristol-Myers Squibb, Eisai, Pfizer, and JW Pharmaceuticals. The authors declare no conflicts of interest.
